Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
Diabetic neuropathy: clinical manifestations and current treatments
Callaghan, B. C., Cheng, H. T., Stables, C. L., Smith, A. L., & Feldman, E. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70065-0 · Cited by 1,211
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915
Descending pain modulation and chronification of pain
Ossipov, M. H., Morimura, K., & Porreca, F. (2014) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000055 · Cited by 815
Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
Hicks, C. W., & Selvin, E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1212-8 · Cited by 798
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
“After adjusting for age and the duration of DM, the risk of peripheral neuropathy is found to be significantly higher in patients with T2DM than in those with T1DM.(306) The median elapsed time to the onset of microproteinuria is also significantly shorter in adolescents with T2DM than in those with T1DM (1.”
BackgroundInfluentialDiabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
Iqbal, Z., Azmi, S., Yadav, R., Ferdousi, M., Kumar, M., Cuthbertson, D. J., Lim, J., Malik, R. A., & Alam, U. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.001 · Cited by 487
“A community-based study in ~15,000 patients with diabetes showed that 34% of patients had symptoms of painful neuropathy, with an increased risk in patients with type 2 diabetes, women, and people of South Asian origin.(17) The prevalence of DPN is considered to be low in patients with early type 1 diabetes; however,…”
BackgroundSelf-citationPathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Neuropathic pain: Definition, assessment and epidemiology
Bouhassira, D. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2018.09.016 · Cited by 398
Diabetes mellitus and its complications in India
Unnikrishnan, R., Anjana, R. M., & Mohan, V. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.53 · Cited by 393
Pain vulnerability: a neurobiological perspective
Denk, F., McMahon, S. B., & Tracey, I. (2014) · Nature Neuroscience · doi:10.1038/nn.3628 · Cited by 363
Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy
Tesfaye, S., Boulton, A. J. M., & Dickenson, A. H. (2013) · Diabetes Care · doi:10.2337/dc12-1964 · Cited by 348
“In a recent study of a large cohort of diabetic patients receiving community-based health care in northwest England (n 5 15,692), painful DSPN assessed using neuropathy symptom and disability scores was found in 21% (7).”
MethodSelf-citationChallenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
“While up to 60% in patients with chronic DM are affected by dPNP, already in newly diagnosed patients, 7–10% suffer from neuropathy (Tracy and Dyck 2008; Tesfaye 2010; Abbott 2011).”
BackgroundThemistocleous, A. C., Ramirez, J. D., Shillo, P. R., Lees, J. G., Selvarajah, D., Orengo, C., Tesfaye, S., Rice, A. S. C., & Bennett, D. L. H. (2016) · Pain · doi:10.1097/j.pain.0000000000000491 · Cited by 313
Schwann cell interactions with axons and microvessels in diabetic neuropathy
Gonçalves, N. P., Vægter, C. B., Andersen, H., Østergaard, L., Calcutt, N. A., & Jensen, T. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.201 · Cited by 305
Distal Symmetric Polyneuropathy: A Review
Callaghan, B. C., Price, R. S., & Feldman, E. L. (2015) · JAMA · doi:10.1001/jama.2015.13611 · Cited by 289
Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain
Leadley, R. M., Armstrong, N., Lee, Y. C., Allen, A., & Kleijnen, J. (2012) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2012.736933 · Cited by 282
Slangen, R., Schaper, N. C., Faber, C. G., Joosten, E. A., Dirksen, C. D., van Dongen, R. T., Kessels, A. G., & van Kleef, M. (2014) · Diabetes Care · doi:10.2337/dc14-0684 · Cited by 264
New perspectives in diabetic neuropathy
Eid, S. A., Rumora, A. E., Beirowski, B., Bennett, D. L., Hur, J., Savelieff, M. G., & Feldman, E. L. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.003 · Cited by 257
Román-Pintos, L. M., Villegas-Rivera, G., Rodríguez-Carrizalez, A. D., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3425617 · Cited by 248
“One study that explores the presence of painful neuropathy demonstrated a prevalence of mild symptoms of 14%, moderate 18%, and severe 16%: the overall presence of painful neuropathy was 34% [47].”
BackgroundChen, X., Graham, J., Dabbah, M. A., Petropoulos, I. N., Ponirakis, G., Asghar, O., Alam, U., Marshall, A., Fadavi, H., Ferdousi, M., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2422 · Cited by 245
Self-citationTreatment of painful diabetic neuropathy
Javed, S., Petropoulos, I. N., Alam, U., & Malik, R. A. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314552071 · Cited by 239
Self-citationDiabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“38,39 In the MONICA/KORA study, the overall prevalence of neuropathic pain was 13.3% among diabetes patients, 8.7% in those with impaired glucose tolerance, 4.2% in those with impaired fasting glucose, and 1.2% in individuals with normal glucose tolerance.”
InfluentialPeltier, A., Goutman, S. A., & Callaghan, B. C. (2014) · BMJ · doi:10.1136/bmj.g1799 · Cited by 218
Diabetic Neuropathies: Diagnosis and Management
Deli, G., Bosnyak, E., Pusch, G., Komoly, S., & Feher, G. (2013) · Neuroendocrinology · doi:10.1159/000358728 · Cited by 226
Alleman, C. J. M., Westerhout, K. Y., Hensen, M., Chambers, C., Stoker, M., Long, S., & van Nooten, F. E. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.031 · Cited by 225
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population
Callaghan, B. C., Xia, R., Reynolds, E., Banerjee, M., Rothberg, A. E., Burant, C. F., Villegas-Umana, E., Pop-Busui, R., & Feldman, E. L. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3745 · Cited by 212
Unlocking the biology of RAGE in diabetic microvascular complications
Manigrasso, M. B., Juranek, J., Ramasamy, R., & Schmidt, A. M. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.08.002 · Cited by 209
A new look at painful diabetic neuropathy
Sloan, G., Shillo, P., Selvarajah, D., Wu, J., Wilkinson, I. D., Tracey, I., Anand, P., & Tesfaye, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.020 · Cited by 189
McDonnell, A., Collins, S., Ali, Z., Iavarone, L., Surujbally, R., Kirby, S., & Butt, R. P. (2018) · Pain · doi:10.1097/j.pain.0000000000001227 · Cited by 186
Painful and Painless Diabetic Neuropathies: What Is the Difference?
Shillo, P., Sloan, G., Greig, M., Hunt, L., Selvarajah, D., Elliott, J., Gandhi, R., Wilkinson, I. D., & Tesfaye, S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1150-5 · Cited by 183
Chronic Pain with Neuropathic Characteristics in Diabetic Patients: A French Cross-Sectional Study
Bouhassira, D., Letanoux, M., & Hartemann, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074195 · Cited by 170
“A structured interview and standardized examination were used in two studies on relatively small cohorts of patients [23,24], whereas only questionnaires – the neuropathy symptom score (NSS) and the neuropathy disability score (NDS) – were used in a much larger cohort of patients receiving community-based health care…”
BackgroundMethodRice, D. A., Kluger, M. T., McNair, P. J., Lewis, G. N., Somogyi, A. A., Borotkanics, R., Barratt, D. T., & Walker, M. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.05.070 · Cited by 168
Raputova, J., Srotova, I., Vlckova, E., Sommer, C., Üçeyler, N., Birklein, F., Rittner, H. L., Rebhorn, C., Adamova, B., Kovalova, I., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000001034 · Cited by 169
Diabetes and Associated Complications in the South Asian Population
Shah, A., & Kanaya, A. M. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0476-5 · Cited by 168
Pain in Chronic Kidney Disease: A Scoping Review
Davison, S. N., Koncicki, H., & Brennan, F. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12196 · Cited by 164
“Large community-based studies of patients with Type 1 and 2 diabetes, using well-defined criteria of painful diabetic neuropathy (PDN) and validated measures of pain severity and quality, have estimated that one-third of all patients have painful diabetic neuropathy (52) and approximately 16% of patients have symptoms…”
BackgroundDidangelos, T., Karlafti, E., Kotzakioulafi, E., Margariti, E., Giannoulaki, P., Batanis, G., Tesfaye, S., & Kantartzis, K. (2021) · Nutrients · doi:10.3390/nu13020395 · Cited by 163
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
Rivera, E., & Cianfrocca, M. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2607-5 · Cited by 159
Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms?
Calcutt, N. A. (2020) · Pain · doi:10.1097/j.pain.0000000000001922 · Cited by 159
Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review
Roohbakhsh, A., Karimi, G., & Iranshahi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.057 · Cited by 169
Kobayashi, M., & Zochodne, D. W. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12833 · Cited by 181
Yang, H., SLOAN, G. P., Ye, Y., Wang, S., Duan, B., Tesfaye, S. H., & Gao, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00929 · Cited by 187
Gylfadottir, S. S., Christensen, D. H., Nicolaisen, S. K., Andersen, H., Callaghan, B. C., Itani, M., Khan, K. S., Kristensen, A. G., Nielsen, J. S., Sindrup, S. H., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001744 · Cited by 151
The global and regional burden of diabetic peripheral neuropathy
Savelieff, M. G., Elafros, M. A., Viswanathan, V., Jensen, T. S., Bennett, D., & Feldman, E. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01041-y · Cited by 194
“…across different countries is difficult, but some studies examined pain prevalence by race and ethnicity within the same country and found higher rates of painful neuropathy symptoms in individuals with diabetes of South Asian heritage than in those of European or Afro-Caribbean heritage 52 .”
Kong, M., Xie, K., Lv, M., Li, J., Yao, J., Yan, K., Wu, X., Xu, Y., & Ye, D. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110975 · Cited by 167
Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres
Burgess, J., Frank, B., Marshall, A. G., Khalil, R. S., Ponirakis, G., Petropoulos, I. N., Cuthbertson, D. J., Malik, R. A., & Alam, U. (2021) · Diagnostics · doi:10.3390/diagnostics11020165 · Cited by 178
Self-citationRare NaV1.7 variants associated with painful diabetic peripheral neuropathy
Blesneac, I., Themistocleous, A. C., Fratter, C., Conrad, L. J., Ramirez, J. D., Cox, J. J., Tesfaye, S. H., SHILLO, P. R., Rice, A. S. C., Tucker, S. J., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000001116 · Cited by 157
Oltean, S., Qiu, Y., Ferguson, J., Stevens, M., Neal, C., Russell, A., Kaura, A., Arkill, K. P., Harris, K., Symonds, C., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040350 · Cited by 136
Baba, M., Matsui, N., Kuroha, M., Wasaki, Y., & Ohwada, S. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13013 · Cited by 136
Vitamin D for the treatment of painful diabetic neuropathy
Basit, A., Basit, K. A., Fawwad, A., Shaheen, F., Fatima, N., Petropoulos, I. N., Alam, U., & Malik, R. A. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000148 · Cited by 138
Self-citationBouhassira, D., Wilhelm, S., Schacht, A., Perrot, S., Kosek, E., Cruccu, G., Freynhagen, R., Tesfaye, S., Lledó, A., Choy, E., et al. (2014) · Pain · doi:10.1016/j.pain.2014.08.020 · Cited by 132
Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats
Abdel‐Moneim, A., Yousef, A. I., El-Twab, S. M. A., Abdel-Reheim, E. S., & Ashour, M. B. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0039-8 · Cited by 142
“Diabetic neuropathy affects nearly 50% of diabetic patients with either type 1 or type 2 diabetes and involves both the peripheral and central nervous systems (Abbott et al. 2011; Selvarajah et al. 2011).”
The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities
Callaghan, B. C., & Feldman, E. L. (2013) · Annals of Neurology · doi:10.1002/ana.23986 · Cited by 147
Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank
Baskozos, G., Hébert, H. L., Pascal, M. M. V., Themistocleous, A. C., Macfarlane, G. J., Wynick, D., Bennett, D. L. H., & Smith, B. H. (2023) · PAIN Reports · doi:10.1097/pr9.0000000000001066 · Cited by 134
“Estimates of NeuP in the general population suggest the prevalence is 7-10% [28], increasing to around 20-30% in people with diabetes [1,2,10,13].”
BackgroundDiabetic peripheral neuropathy may not be as its name suggests
Tesfaye, S. H., Selvarajah, D., Gandhi, R. A., Greig, M., SHILLO, P. R., Fang, F., & Wilkinson, I. D. (2015) · Pain · doi:10.1097/j.pain.0000000000000465 · Cited by 122
Risk factors for neuropathic pain in diabetes mellitus
Hébert, H. L., Veluchamy, A., Torrance, N., & Smith, B. H. (2016) · Pain · doi:10.1097/j.pain.0000000000000785 · Cited by 129
Corneal confocal microscopy: ready for prime time
Petropoulos, I. N., Ponirakis, G., Khan, A., Gad, H., Almuhannadi, H., Brines, M. L., Cerami, A., & Malik, R. A. (2019) · Clinical and Experimental Optometry · doi:10.1111/cxo.12887 · Cited by 118
Self-citationSmall fiber neuropathy: diagnosis, causes, and treatment
Sène, D. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.11.002 · Cited by 113
Demaré, S., Kothari, A., Calcutt, N. A., & Fernyhough, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1847645 · Cited by 125
Zilliox, L. A. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000462 · Cited by 126
Lu, Y., Xing, P., Cai, X., Luo, D., Li, R., Lloyd, C. E., Sartorius, N., & Li, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.534372 · Cited by 148
“While the overall prevalence for DPN found in our study for adults with T2DM was similar to that reported previously (20), our estimates for prevalence of DPN in different countries varied substantially: ranging from 0.”
ResultPaisey, R., Abbott, A., Levenson, R., Harrington, A., Browne, D., Moore, J., Bamford, M., & Roe, M. (2017) · Diabetic Medicine · doi:10.1111/dme.13512 · Cited by 112
Hicks, C. W., Canner, J. K., Mathioudakis, N. N., Lippincott, C. K., Sherman, R. L., & Abularrage, C. J. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.09.025 · Cited by 129
Treating pain in diabetic neuropathy: current and developmental drugs
Alam, U., Sloan, G., & Tesfaye, S. (2020) · Drugs · doi:10.1007/s40265-020-01259-2 · Cited by 104
“There was an increased risk of painful symptoms in patients with T2D, women and people of South Asian origin [7].”
BackgroundKim, S. S., Won, J. C., Kwon, H., Kim, C. H., Lee, J. H., Park, T. S., Ko, K. S., & Cha, B. Y. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.003 · Cited by 103
“Pain associated with DPN substantially and negatively affects quality of life in these patients [8,9].”
BackgroundResultInfluentialWhyte, M., Hinton, W., McGovern, A. P., van Vlymen, J. N., Ferreira, F. M., Calderara, S., Mount, J., Munro, N. M., & de Lusignan, S. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002942 · Cited by 103
Kalteniece, A., Ferdousi, M., Petropoulos, I. N., Azmi, S., Adam, S., Fadavi, H., Marshall, A. G., Boulton, A. J. M., Efron, N., Faber, C. G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21643-z · Cited by 102
Self-citationGlial cell alterations in diabetes-induced neurodegeneration
Llorián‐Salvador, M., Cabeza‐Fernández, S., Gomez-Sanchez, J. A., & de la Fuente, A. G. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05024-y · Cited by 114
“…of the total National Health System expenditures [3–5] due to its strong association with several disabling complications, including alterations in the peripheral (PNS) and central nervous system (CNS) such as peripheral neuropathy, and diabetic retinopathy or cognitive decline, respectively [5–8].”
BackgroundThe Inferior Whorl For Detecting Diabetic Peripheral Neuropathy Using Corneal Confocal Microscopy
Petropoulos, I. N., Ferdousi, M., Marshall, A. G., Alam, U., Ponirakis, G., Azmi, S., Fadavi, H., Efron, N., Tavakoli, M., & Malik, R. A. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15919 · Cited by 107
Self-citationReduced vitamin D levels in painful diabetic peripheral neuropathy
SHILLO, P. R., Selvarajah, D., Greig, M., Gandhi, R. A., Rao, G., Wilkinson, I. D., Anand, P., & Tesfaye, S. H. (2018) · Diabetic Medicine · doi:10.1111/dme.13798 · Cited by 102
Pathophysiology of diabetes mellitus complications: Metabolic events and control
Ohiagu, F. O., Chikezie, P. C., & Chikezie, C. M. (2021) · Biomedical Research and Therapy · doi:10.15419/bmrat.v8i3.663 · Cited by 146
Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions
Javed, S., Alam, U., & Malik, R. A. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.63 · Cited by 101
“In about one fifth of patients, painful diabetic peripheral neuropathy (pDPN) predominates, and has a significant negative impact on health-related quality of life and general function [7].”
BackgroundSelf-citationGenetics of diabetes-associated microvascular complications
Lyssenko, V., & Vaag, A. A. (2023) · Diabetologia · doi:10.1007/s00125-023-05964-x · Cited by 113
Su, K., Deng, D., Wu, X., Song, Y., Song, Y., Wang, X., Zhang, Z., Li, J., Yan, Z., Shang, X., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.147646 · Cited by 96
Painful and Painless Diabetic Neuropathy: One Disease or Two?
Spallone, V., & Greco, C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0387-7 · Cited by 95
“A few studies have addressed the relationship between neuropathic pain and DPN severity [4, 7, 29, 39, 56, 57] (Table 1).”
BackgroundInfluentialAromatherapy Massage for Neuropathic Pain and Quality of Life in Diabetic Patients
Metin, Z. G., Dönmez, A. A., İzgü, N., Özdemir, L., & Arslan, I. E. (2017) · Journal of Nursing Scholarship · doi:10.1111/jnu.12300 · Cited by 91
Sommer, C., Geber, C., Young, P., Forst, R., Birklein, F., & Schoser, B. G. H. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0083 · Cited by 99
Corneal Confocal Microscopy to Assess Diabetic Neuropathy: An Eye on the Foot
Tavakoli, M., Petropoulos, I. N., & Malik, R. A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700509 · Cited by 91
Self-citationWhither pathogenetic treatments for diabetic polyneuropathy?
Boulton, A. J. M., Kempler, P., As, A., & Ziegler, D. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2397 · Cited by 93
“Symptoms of pain have been reported to occur in 13–34% of patients with diabetes, with the risk of painful neuropathic symptoms considerably higher in type 2 diabetes than in type 1 diabetes [4,5].”
BackgroundSelf-citationMeng, W., Deshmukh, H., Donnelly, L. A., Torrance, N., Colhoun, H. M., Palmer, C. N. A., & Smith, B. H. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.001 · Cited by 93
“The prevalence of neuropathic pain is estimated to be around 7% in a general population while in a diabetic population around 1 in 4 patients will suffer from this disorder (van Hecke et al., 2014; Abbott et al., 2011).”
BackgroundMizokami‐Stout, K., Li, Z., Foster, N. C., Shah, V. N., Aleppo, G., McGill, J. B., Pratley, R. E., Toschi, E., Ang, L. P., Pop‐Busui, R., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1583 · Cited by 96
Differential cellular localization of antioxidant enzymes in the trigeminal ganglion
Sato, H., Shibata, M., Shimizu, T., Shibata, S., Toriumi, H., Ebine, T., Kuroi, T., Iwashita, T., Funakubo, M., Kayama, Y., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.010 · Cited by 92
Truini, A., Spallone, V., Morganti, R., Tamburin, S., Zanette, G., Schenone, A., De Michelis, C., Tugnoli, V., Simioni, V., Manganelli, F., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001378 · Cited by 85
Pathogenesis of Painful Diabetic Neuropathy
Aslam, A., Singh, J., & Rajbhandari, S. M. (2014) · Pain Research and Treatment · doi:10.1155/2014/412041 · Cited by 108
Chen, X., Graham, J., Petropoulos, I., Ponirakis, G., Asghar, O., Alam, U., Marshall, A., Ferdousi, M., Azmi, S., Efron, N., et al. (2018) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.17-23342 · Cited by 80
“Diabetic sensorimotor polyneuropathy (DSPN) affects at least 50% of patients with diabetes.(1) Earlier diagnosis and timely intervention to prevent progression to costly outcomes like foot ulceration could reduce not only morbidity but also mortality.”
BackgroundSelf-citationNeuropathic pain in the community: prevalence, impact, and risk factors
Smith, B. H., Hébert, H. L., & Veluchamy, A. (2020) · Pain · doi:10.1097/j.pain.0000000000001824 · Cited by 94
Meng, W., Deshmukh, H., van Zuydam, N. R., Liu, Y., Donnelly, L. A., Zhou, K., Surrogate Markers for Micro‐ and Macro‐Vascular Hard Endpoints for Innovative Diabetes Tools (SUMMIT) Study Group, Morris, A. D., Colhoun, H. M., Palmer, C. N. A., et al. (2014) · European Journal of Pain · doi:10.1002/ejp.560 · Cited by 90
“Furthermore, we found a similar gender distribution, with a female : male ratio of 1.32, compared with 1.21 (Abbott et al., 2011), and this tends to support the validity of our phenotype.”
InfluentialVieira, W. F., Coelho, D. R. A., Litwiler, S. T., McEachern, K. M., Clancy, J. A., Morales-Quezada, L., & Cassano, P. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105673 · Cited by 96
Zhang, H.-H., Hu, J., Zhou, Y. L., Qin, X., Song, Z.-Y., Yang, P.-P., Hu, S., Jiang, X., & Xu, G. (2015) · Diabetes · doi:10.2337/db15-0138 · Cited by 83
Pai, Y., Lin, C., Lee, I., & Chang, M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.09.013 · Cited by 78
Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial
The Vitamin E in Neuroprotection Study (VENUS) Investigators, Hor, C. P., Fung, W.-Y., Ang, H. A., Lim, S. C., Kam, L. Y., Sim, S.-W., Lim, L. H., Choon, W. Y., Wong, J. W., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4609 · Cited by 87
Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy
Yoo, M., D’Silva, L. J., Martin, K., Sharma, N. K., Pasnoor, M., LeMaster, J. W., & Kluding, P. M. (2015) · Pain Medicine · doi:10.1111/pme.12743 · Cited by 82
Diabetes in South Asians: Phenotype, Clinical Presentation, and Natural History
Ranjit Unnikrishnan, I., Gupta, P. K., & Mohan, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1002-8 · Cited by 92
Neuropathic Pain in the Elderly
Giovannini, S., Coraci, D., Brau, F., Galluzzo, V., Loreti, C., Caliandro, P., Padua, L., Maccauro, G., Biscotti, L., & Bernabei, R. (2021) · Diagnostics · doi:10.3390/diagnostics11040613 · Cited by 88
“Considering that painful diabetic neuropathy affects one third of adults with diabetes mellitus [13], the prevalence of the neuropathic component of pain among older people should be higher than expected.”
BackgroundKisozi, T., Mutebi, E. I., Musubire, A. K., Lhatoo, S. D., Sajatovic, M., Kaddumukasa, M., Nakwagala, F. N., & Katabira, E. (2017) · African Health Sciences · doi:10.4314/ahs.v17i2.21 · Cited by 81
Role of Acupuncture in the Management of Diabetic Painful Neuropathy (Dpn): A Pilot Rct
Garrow, A. P., Xing, M., Vere, J., Verrall, B., Wang, L., & Jude, E. B. (2014) · Acupuncture in Medicine · doi:10.1136/acupmed-2013-010495 · Cited by 78
Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy
Marshall, A. G., Lee-Kubli, C. A., Azmi, S., Zhang, M., Ferdousi, M., Mixcoatl-Zecuatl, T., Petropoulos, I. N., Ponirakis, G., Fineman, M. S., Fadavi, H., et al. (2017) · Diabetes · doi:10.2337/db16-1181 · Cited by 76
Self-citationGPR177 in A-fiber sensory neurons drives diabetic neuropathic pain via WNT-mediated TRPV1 activation
Xie, Y., Luo, H., Zhang, S.-X., Chen, X., Guo, R., Liu, S., Liu, S., Wu, H. B. K., Zhen, X., Zhen, X., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abh2557 · Cited by 89
“DNP is characterized by mechanical allodynia, spontaneous pain, and paresthesia (tingling, shooting, or electric shock sensations), affecting 25 to 30% of patients with diabetes (1, 2).”
Background
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
